VASO Corp (VASO) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US92233F1021
VASO Corp financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 89.10 m USD |
| Gross profit | 54.67 m USD |
| Operating income | -2.89 m USD |
| EBIT | -1.31 m USD |
| Net income | 1.57 m USD |
| Diluted EPS – continuing operations | 0.01 USD |
Full history since 1989, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About VASO Corp
Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. It operates in three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed network infrastructure, such as routers, switches, and other core equipment; managed network transport; and managed network security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare, Inc. (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging equipment and ultrasound systems, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices and software. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure signals, including cloud-based software and algorithm subscription services; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems for non-invasive and outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York.
More stocks
- Greenland Mines Ltd (GRML)
- OFS Capital Corp (OFS)
- Sewon Corporation Co.Ltd (024830.KQ)
- MYOMO, INC. (MYO)
- Aura Energy Ltd (AEE.AX)
- Senko Co. Ltd (347000.KQ)
- InkTec Co. Ltd (049550.KQ)
- Mereo BioPharma Group plc (MREO)
- Gold Hydrogen Ltd (GHY.AX)
- Quality & Reliability A.B.E.E (QUAL.AT)
- Chosun Welding (120030.KS)
- Arizona Gold & Silver Inc. (AZS.V)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.